(Q33419261)

26 July 2017

1 reference

title

Complement regulators in human disease: lessons from modern genetics (English)

1 reference

26 July 2017

M K Liszewski

1

1 reference

26 July 2017

J P Atkinson

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

16 January 2015

1 reference

Journal of Internal Medicine

26 July 2017

published in

1 reference

26 July 2017

volume

277

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

294-305

1 reference

Molecular intercommunication between the complement and coagulation systems

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement and coagulation: strangers or partners in crime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Clinical significance of complement deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Genetics of atypical hemolytic uremic syndrome (aHUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Genetic variants in the complement system predisposing to age-related macular degeneration: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement factor H polymorphism in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Variation in complement factor 3 is associated with risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Seven new loci associated with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement regulatory genes and hemolytic uremic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Factor C acts as a lipopolysaccharide-responsive C3 convertase in horseshoe crab complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

The ancient origin of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Genomic view of the evolution of the complement system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement systems in invertebrates. The ancient alternative and lectin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

The amplification loop of the complement pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement evasion by human pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

The central role of the alternative complement pathway in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

The spectrum of complement alternative pathway-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Advances in understanding of pathogenesis of aHUS and HELLP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Functional anatomy of complement factor H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

CD46 in innate and adaptive immunity: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Emerging roles and new functions of CD46

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Anti-factor H autoantibody-associated hemolytic uremic syndrome: the earlier diagnosed and treated, the better

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement factor H polymorphism and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement factor H variant increases the risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Acquisition of complement factor H is important for pathogenesis of Streptococcus pyogenes infections: evidence from bacterial in vitro survival and human genetic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement C3 variant and the risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

A rare penetrant mutation in CFH confers high risk of age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Identification of a rare coding variant in complement 3 associated with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Therapeutic potential of complement modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement-targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Eculizumab: a review of its use in atypical haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Defective complement inhibitory function predisposes to renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

Diagnosis and management of complement mediated thrombotic microangiopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12338

21 January 2018

Identifiers

DOI

10.1111/JOIM.12338

1 reference

26 July 2017

1 reference